Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  recombinant CD40-ligand
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-7 of 7 for your search:
Start Over
Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: over 18
Sponsor: Other
Protocol IDs: CDR0000270762, ERLANGEN-ONTAK, EU-20246, NCT00056134
Phase I Study of CD40-Ligand (CD154) Gene-Transduced Leukemia Cells in Patients with Chronic Lymphocytic Leukemia
Phase: Phase I
Type: Treatment
Status: Closed
Age: Over 21
Sponsor: NCI
Protocol IDs: UCSD-970976, NCI-G98-1477
Biological Therapy in Treating Patients With Metastatic Melanoma or Metastatic Kidney Cancer
Phase: Phase I
Type: Treatment
Status: Completed
Age: 16 and over
Sponsor: NCI
Protocol IDs: CDR0000068601, NCI-01-C-0121, NCI-1035, 1035, NCT00020540
Gene-Modified Cancer Cells in Treating Patients With B-Cell Chronic Lymphocytic Leukemia
Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: CDR0000582397, BCM-H-11541, BCM-CLIMAT, NCT00609076
Treating High Risk Leukemia With CD40 Ligand & IL-2 Gene Modified Tumor Vaccine
Phase: Phase I
Type: Treatment
Status: Completed
Age: 75 and under
Sponsor: Other
Protocol IDs: H6408-Leu Leu, NCT00058799
Treatment of B-CLL With Human IL-2 and CD40 Ligand and Plasmid Gene Modified Autologous Tumor Cells
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: H11967, CLIPA, NCT00078520
Start Over